This page follows insider dealings at Veritas Pharma Inc. as filed with SEDI. Veritas Pharma Inc. has had no insider filing for more than a year; the last one goes back to 24 September 2021.
Over the whole record (from 2016), the tally stands at 8 purchases and 26 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 54 declarations
Veritas Pharma Inc. is a Canadian company listed on the Toronto Stock Exchange, specializing in the development of cannabis-based pharmaceutical products. It focuses on the research and commercialization of innovative medical treatments.